Tolbutamide causes open channel blockade of cystic fibrosis transmembrane conductance regulator Cl-channels
Ozempic and Cardiovascular Health Concerns Ozempic, a medication commonly prescribed for type 2 diabetes and weight loss, has garnered attention due to its potential impacts on cardiovascular health
Cronometer Best for Macro Tracking The nutrition challenge on GLP-1 medications is specific: you are eating significantly less, which means every meal has to count more
The TWILIGHT trial 113 is a double-blind superiority study that will compare the efficacy and safety of antiplatelet therapy with ticagrelor versus that of continued DAPT with acetylsalicylic acid and ticagrelor in 9,000 high-risk patients receiving DAPT who are event-free at 3 months after PCI with drug-eluting stents
What stands out from this research is that people arent looking to abandon effective treatment
Compounding pharmacies that market microdosed GLP-1 medications for gradual weight loss, longevity, or other benefits typically provide their medications in a glass vial